Breast Cancer Risk Biomarkers in Premenopausal Women
NCT01252277
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Lovaza™
Sponsor
Carol Fabian, MD